US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 37.500
  • -1.730-4.41%
Trading Mar 11 10:40 ET
5.89BMarket Cap250.00P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-28.98%-40.52M
-94.10%-25.64M
-114.58%-12.21M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.66%-13.21M
342.66%83.7M
14.48%-42.01M
12.79%-59.9M
Net income from continuing operations
84.52%23.38M
261.84%23.33M
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
105.66%12.67M
81.63%-14.42M
418.08%113.93M
-17.52%-47.61M
43.15%-39.23M
Operating gains losses
--4.61M
--0
----
----
----
----
----
----
----
----
Depreciation and amortization
-33.81%280K
-31.87%62K
-49.21%64K
-15.29%72K
-32.23%82K
-17.86%423K
-27.78%91K
-2.33%126K
-35.11%85K
-6.20%121K
Other non cash items
-5.73%4.2M
-27.34%954K
31.39%1.04M
-10.75%1.2M
0.00%1.01M
0.25%4.45M
19.80%1.31M
-53.17%790K
93.08%1.34M
4.66%1.01M
Change In working capital
-29.10%-109.3M
-654.44%-60.74M
20.65%-31.83M
-30.44%-10.67M
78.58%-6.07M
-5,040.19%-84.66M
-147.33%-8.05M
-447.47%-40.11M
2.85%-8.18M
-871.66%-28.32M
-Change in receivables
-52.84%-78.09M
-14.31%-13.46M
-47.09%-32.12M
-110.20%-18.63M
-61.07%-13.89M
-3,778.40%-51.09M
---11.77M
-24,913.64%-21.84M
-1,188.57%-8.86M
-1,870.64%-8.62M
-Change in inventory
-80.98%-66.85M
-350.78%-24.82M
-0.16%-2.54M
-29.82%-2.56M
-37.17%-36.93M
---36.94M
---5.51M
---2.54M
---1.97M
---26.92M
-Change in payables and accrued expense
11,794.79%22.84M
-1,582.53%-38.01M
154.25%11.67M
-3.44%8.96M
308.01%40.22M
101.74%192K
-84.39%2.56M
-253.69%-21.51M
182.95%9.28M
196.93%9.86M
-Change in other current assets
-123.10%-6.32M
122.07%16.73M
-2,339.18%-25.59M
115.69%1.05M
156.81%1.49M
-134.60%-2.83M
2,122.42%7.53M
-394.81%-1.05M
-616.83%-6.69M
-138.81%-2.62M
-Change in other current liabilities
447.00%1.64M
935.71%580K
-1,388.89%-1.39M
-87.27%14K
9,280.77%2.44M
645.45%300K
-80.21%56K
109.97%108K
-84.24%110K
-44.68%26K
-Change in other working capital
206.13%17.48M
-90.17%-1.76M
170.28%18.14M
1,410.53%498K
1,684.21%602K
3,857.24%5.71M
-2,336.84%-926K
17,765.79%6.71M
0.00%-38K
0.00%-38K
Cash from discontinued investing activities
Operating cash flow
-28.98%-40.52M
-94.10%-25.64M
-114.58%-12.21M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.66%-13.21M
342.66%83.7M
14.48%-42.01M
12.79%-59.9M
Investing cash flow
Cash flow from continuing investing activities
97.95%-1.04M
135.28%15.79M
69.12%-9.33M
-94.21%1.77M
-50.05%-9.26M
-153.09%-50.65M
-375.09%-44.76M
-911.00%-30.23M
193.87%30.5M
85.88%-6.17M
Net PPE purchase and sale
---45K
---21K
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
98.04%-991K
135.32%15.81M
69.20%-9.31M
-94.21%1.77M
-50.05%-9.26M
-153.27%-50.65M
-375.04%-44.76M
-912.36%-30.23M
193.87%30.5M
85.87%-6.17M
Cash from discontinued investing activities
Investing cash flow
97.95%-1.04M
135.28%15.79M
69.12%-9.33M
-94.21%1.77M
-50.05%-9.26M
-153.09%-50.65M
-375.09%-44.76M
-911.00%-30.23M
193.87%30.5M
85.88%-6.17M
Financing cash flow
Cash flow from continuing financing activities
76.78%128.53M
-607,100.00%-6.07M
31,836.82%134.45M
-99.71%135K
-99.96%10K
18,694.63%72.71M
-102.04%-1K
53.09%421K
34,749.63%47.05M
3,069.18%25.24M
Net issuance payments of debt
449.05%137.26M
--0
--137.26M
----
----
2,664.10%25M
--0
--0
--0
2,664.10%25M
Net common stock issuance
-118.92%-8.76M
-661,000.00%-6.61M
-215,000.00%-2.15M
----
----
--46.3M
---1K
--1K
----
----
Proceeds from stock option exercised by employees
-40.42%914K
--570K
-52.62%199K
-82.02%135K
-97.25%10K
162.67%1.53M
--0
52.73%420K
456.30%751K
190.40%363K
Net other financing activities
-611.20%-889K
---31K
----
----
----
---125K
--0
----
----
---125K
Cash from discontinued financing activities
Financing cash flow
76.78%128.53M
-607,100.00%-6.07M
31,836.82%134.45M
-99.71%135K
-99.96%10K
18,694.63%72.71M
-102.04%-1K
53.09%421K
34,749.63%47.05M
3,069.18%25.24M
Net cash flow
Beginning cash position
-9.04%94.22M
29.53%197.12M
-14.33%84.2M
22.35%76.77M
-9.04%94.22M
-65.49%103.58M
36.94%152.18M
-33.74%98.29M
-66.44%62.75M
-65.49%103.58M
Current changes in cash
1,029.31%86.97M
72.53%-15.93M
109.51%112.92M
-79.08%7.44M
57.26%-17.45M
95.24%-9.36M
-667.56%-57.97M
244.84%53.9M
192.08%35.54M
63.93%-40.83M
End cash Position
92.31%181.19M
92.31%181.19M
29.53%197.12M
-14.33%84.2M
22.35%76.77M
-9.04%94.22M
-9.04%94.22M
36.94%152.18M
-33.74%98.29M
-66.44%62.75M
Free cash flow
-29.12%-40.56M
-94.26%-25.66M
-114.61%-12.23M
113.18%5.54M
86.30%-8.21M
82.17%-31.41M
44.67%-13.21M
342.63%83.7M
14.48%-42.01M
12.80%-59.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -28.98%-40.52M-94.10%-25.64M-114.58%-12.21M113.18%5.54M86.30%-8.21M82.17%-31.41M44.66%-13.21M342.66%83.7M14.48%-42.01M12.79%-59.9M
Net income from continuing operations 84.52%23.38M261.84%23.33M-96.59%3.88M114.45%6.88M72.71%-10.71M105.66%12.67M81.63%-14.42M418.08%113.93M-17.52%-47.61M43.15%-39.23M
Operating gains losses --4.61M--0--------------------------------
Depreciation and amortization -33.81%280K-31.87%62K-49.21%64K-15.29%72K-32.23%82K-17.86%423K-27.78%91K-2.33%126K-35.11%85K-6.20%121K
Other non cash items -5.73%4.2M-27.34%954K31.39%1.04M-10.75%1.2M0.00%1.01M0.25%4.45M19.80%1.31M-53.17%790K93.08%1.34M4.66%1.01M
Change In working capital -29.10%-109.3M-654.44%-60.74M20.65%-31.83M-30.44%-10.67M78.58%-6.07M-5,040.19%-84.66M-147.33%-8.05M-447.47%-40.11M2.85%-8.18M-871.66%-28.32M
-Change in receivables -52.84%-78.09M-14.31%-13.46M-47.09%-32.12M-110.20%-18.63M-61.07%-13.89M-3,778.40%-51.09M---11.77M-24,913.64%-21.84M-1,188.57%-8.86M-1,870.64%-8.62M
-Change in inventory -80.98%-66.85M-350.78%-24.82M-0.16%-2.54M-29.82%-2.56M-37.17%-36.93M---36.94M---5.51M---2.54M---1.97M---26.92M
-Change in payables and accrued expense 11,794.79%22.84M-1,582.53%-38.01M154.25%11.67M-3.44%8.96M308.01%40.22M101.74%192K-84.39%2.56M-253.69%-21.51M182.95%9.28M196.93%9.86M
-Change in other current assets -123.10%-6.32M122.07%16.73M-2,339.18%-25.59M115.69%1.05M156.81%1.49M-134.60%-2.83M2,122.42%7.53M-394.81%-1.05M-616.83%-6.69M-138.81%-2.62M
-Change in other current liabilities 447.00%1.64M935.71%580K-1,388.89%-1.39M-87.27%14K9,280.77%2.44M645.45%300K-80.21%56K109.97%108K-84.24%110K-44.68%26K
-Change in other working capital 206.13%17.48M-90.17%-1.76M170.28%18.14M1,410.53%498K1,684.21%602K3,857.24%5.71M-2,336.84%-926K17,765.79%6.71M0.00%-38K0.00%-38K
Cash from discontinued investing activities
Operating cash flow -28.98%-40.52M-94.10%-25.64M-114.58%-12.21M113.18%5.54M86.30%-8.21M82.17%-31.41M44.66%-13.21M342.66%83.7M14.48%-42.01M12.79%-59.9M
Investing cash flow
Cash flow from continuing investing activities 97.95%-1.04M135.28%15.79M69.12%-9.33M-94.21%1.77M-50.05%-9.26M-153.09%-50.65M-375.09%-44.76M-911.00%-30.23M193.87%30.5M85.88%-6.17M
Net PPE purchase and sale ---45K---21K--------------0--0------------
Net investment purchase and sale 98.04%-991K135.32%15.81M69.20%-9.31M-94.21%1.77M-50.05%-9.26M-153.27%-50.65M-375.04%-44.76M-912.36%-30.23M193.87%30.5M85.87%-6.17M
Cash from discontinued investing activities
Investing cash flow 97.95%-1.04M135.28%15.79M69.12%-9.33M-94.21%1.77M-50.05%-9.26M-153.09%-50.65M-375.09%-44.76M-911.00%-30.23M193.87%30.5M85.88%-6.17M
Financing cash flow
Cash flow from continuing financing activities 76.78%128.53M-607,100.00%-6.07M31,836.82%134.45M-99.71%135K-99.96%10K18,694.63%72.71M-102.04%-1K53.09%421K34,749.63%47.05M3,069.18%25.24M
Net issuance payments of debt 449.05%137.26M--0--137.26M--------2,664.10%25M--0--0--02,664.10%25M
Net common stock issuance -118.92%-8.76M-661,000.00%-6.61M-215,000.00%-2.15M----------46.3M---1K--1K--------
Proceeds from stock option exercised by employees -40.42%914K--570K-52.62%199K-82.02%135K-97.25%10K162.67%1.53M--052.73%420K456.30%751K190.40%363K
Net other financing activities -611.20%-889K---31K---------------125K--0-----------125K
Cash from discontinued financing activities
Financing cash flow 76.78%128.53M-607,100.00%-6.07M31,836.82%134.45M-99.71%135K-99.96%10K18,694.63%72.71M-102.04%-1K53.09%421K34,749.63%47.05M3,069.18%25.24M
Net cash flow
Beginning cash position -9.04%94.22M29.53%197.12M-14.33%84.2M22.35%76.77M-9.04%94.22M-65.49%103.58M36.94%152.18M-33.74%98.29M-66.44%62.75M-65.49%103.58M
Current changes in cash 1,029.31%86.97M72.53%-15.93M109.51%112.92M-79.08%7.44M57.26%-17.45M95.24%-9.36M-667.56%-57.97M244.84%53.9M192.08%35.54M63.93%-40.83M
End cash Position 92.31%181.19M92.31%181.19M29.53%197.12M-14.33%84.2M22.35%76.77M-9.04%94.22M-9.04%94.22M36.94%152.18M-33.74%98.29M-66.44%62.75M
Free cash flow -29.12%-40.56M-94.26%-25.66M-114.61%-12.23M113.18%5.54M86.30%-8.21M82.17%-31.41M44.67%-13.21M342.63%83.7M14.48%-42.01M12.80%-59.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Coinbase
COIN
+2.70%
Microsoft
MSFT
+0.81%
Salesforce
CRM
+0.78%
Meta Platforms
META
+0.63%
Amazon
AMZN
+0.65%

Unlock the Full List